Aprepitant for refractory nivolumab-induced pruritus.
Sign Up to like & getrecommendations! Published in 2017 at "Lung cancer"
DOI: 10.1016/j.lungcan.2017.04.020
Abstract: Although substantial progress has been made in the treatment of non-small-cell lung cancer (NSCLC) patients with immune checkpoint inhibitors (ICIs), severe immune-related adverse events (irAEs) sometimes occur. Here, we report a case of severe refractory… read more here.
Keywords: aprepitant refractory; refractory nivolumab; refractory pruritus; pruritus ... See more keywords
Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients
Sign Up to like & getrecommendations! Published in 2023 at "Renal Failure"
DOI: 10.1080/0886022x.2023.2175590
Abstract: Abstract Background: Chronic kidney disease-associated pruritus (CKD-aP) is very common and sometimes refractory to treatment in hemodialysis patients. In a trial conducted in Japan, nalfurafine, effectively reduced itching of treatment-resistant CKD-aP. Our present bridging study… read more here.
Keywords: trial; ckd; refractory pruritus; hemodialysis patients ... See more keywords